Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,461 | 549 | 10,055 | 5,005 | 14,040 |
| Receivables | 883 | N/A | N/A | N/A | N/A |
| Other current assets | 21 | 203 | 0 | 0 | 0 |
| TOTAL | $8,659 | $1,591 | $12,565 | $7,478 | $15,496 |
| Non-Current Assets | |||||
| PPE Net | 6 | 5 | 6 | 16 | 23 |
| Other Non-Current Assets | 36 | 105 | 483 | 1,264 | 334 |
| TOTAL | $42 | $110 | $489 | $1,280 | $358 |
| Total Assets | $8,701 | $1,701 | $13,053 | $8,757 | $15,853 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,198 | 5,832 | 4,510 | 1,981 | 946 |
| Accrued Expenses | N/A | N/A | N/A | 225 | 520 |
| TOTAL | $2,524 | $6,133 | $4,920 | $2,594 | $1,905 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,524 | $6,133 | $4,920 | $2,594 | $1,905 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 245 | 0 | 0 | 0 | 0 |
| Common Shares | 1 | 0 | 2 | 1 | 24 |
| Retained earnings | -84,425 | -69,567 | -50,716 | -35,442 | -20,946 |
| TOTAL | $6,177 | $-4,432 | $8,133 | $6,163 | $13,948 |
| Total Liabilities And Equity | $8,701 | $1,701 | $13,053 | $8,757 | $15,853 |